Направленная радионуклидная терапия: современное состояние и перспективы

Translated title of the contribution: Targeted radionuclide therapy: current status and prospects

V. A. Vodeneev, A. V. Zvyagin, N. Yu Shilyagina, D. A. Kulikov, A. V. Kulikov, S. V. Gudkov

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


One of the intensively developing approaches to the treatment of oncologic diseases is directed (targeted) radionuclide therapy. Radionuclide therapy avoids the side effects associated with external beam therapy. Furthermore, it is possible to combine the processes instrumental diagnostics and radiotherapy (theranostics), which leads to personalize the treatment regimen for each individual patient. In this review, we discuss the fundamentals of targeted radionuclide therapy, including the characteristics of the radionuclides and biomolecular targeting moieties. Information on the targeted radionuclide therapy drugs for approved for clinical use is provided. Prospects and limitations of the targeted radionuclide therapy and their implementation in clinical practice are discussed.

Translated title of the contributionTargeted radionuclide therapy: current status and prospects
Original languageRussian
Pages (from-to)23-29
Number of pages7
JournalGenes and Cells
Issue number2
Publication statusPublished - 1 Dec 2015
Externally publishedYes


  • oncological diseases
  • radioimmunotherapy
  • targeted drugs
  • targeted radionuclide therapy
  • tumour cells


Dive into the research topics of 'Targeted radionuclide therapy: current status and prospects'. Together they form a unique fingerprint.

Cite this